Use of a nitric oxide precursor to protect pig myocutaneous flaps from ischemia-reperfusion injury

Plastic and Reconstructive Surgery

Volumn 102, Issue 6, 1998, Pages 2040-2051

  Cordeiro, Peter G ^a   Santamaria, Eric ^a   Hu, Qun Ying ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; MYELOPEROXIDASE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROBLUE TETRAZOLIUM; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; MUSCLE BIOPSY; MUSCLE NECROSIS; MYOCUTANEOUS FLAP; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; WATER CONTENT;

EID: 0031773226     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199811000-00035     Document Type: Article

References (64)

1. Granger, N. D., and Korthuis, R. J. Physiologic mechanisms of postischemic tissue injury. Annu. Rev. Physiol. 57: 311, 1995.
2. Picard-Ami, L. A., Jr., Thomson, J. G., and Kerrigan, C. L. Critical ischemia times and survival patterns of experimental pig flaps. Plast. Reconstr. Surg. 86: 739, 1990.
3. Wright, J. G., Fox, D., Kerr, J. C., et al. Rate of reperfusion blood flow modulates reperfusion injury in skeletal muscle. J. Surg. Res. 44: 754, 1988.
4. Kerrigan, C. L., and Daniel, R. K. Pharmacologic treatment of the failing skin flap. Plast. Reconstr. Surg. 70: 541, 1982.
5. Pang, C. Y., Forrest, C. R., Mounsey, R., et al. Pharmacologic intervention in ischemia-induced reperfusion injury in the skeletal muscle. Microsurgery 14: 176, 1993.
6. Shin, M.-S., Angel, M. F., Im, M. J., et al. Effects of 21-aminosteroid U74389F on skin-flap survival after secondary ischemia. Plast. Reconstr. Surg. 94: 661, 1994.
7. Morris, S. F., Pang, C. Y., Lofchy, N. M., et al. Deferoxamine attenuates ischemia-induced reperfusion injury in the skin and muscle of myocutaneous flaps in the pig. Plast. Reconstr. Surg. 92: 120, 1993.
8. Walker, P. M., Lindsay, T. F., Labbe, R., et al. Salvage of skeletal muscle with free radical scavengers. J. Vasc. Surg. 5: 68, 1987.
9. Manson, P. N., Anthenelli, R. M., Im, M. J., et al. The role of oxygen free radicals in ischemic tissue injury in island skin flaps. Ann. Surg. 298: 87, 1983.
10. Angel, M. F., Ramasastry, S. S., Swartz, W. M., et al. The critical relationship between free radicals and degrees of ischemia: Evidence for tissue intolerance of marginal perfusion. Plast. Reconstr. Surg. 81: 233, 1988.
11. Suzuki, M., Inauen, W., Kvietys, P. R., et al. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am. J. Physiol. 257: H1740, 1989.
12. Rubin, B. B., Chang, G., Liauw, S., et al. Phospholipid peroxidation deacylation and remodeling in postischemic skeletal muscle. Am. J. Physiol. 263: H1695, 1992.
13. Lee, C., and Kerrigan, C. L. Neutrophil localization following reperfusion of ischemic skin flaps. Plast. Reconstr. Surg. 89: 910, 1992.
14. Lee, C., Kerrigan, C. L., and Tellado, J. M. Altered neutrophil function following reperfusion of an ischemic myocutaneous flap. Plast. Reconstr. Surg. 89: 916, 1992.
15. Granger, D. N., Benoit, J. N., Suzuki, M., et al. Leukocyte adherence to venular endothelium during ischemia-repertusion. Am. J. Physiol. 257: G683, 1989.
16. Shaheen, K. W., Punch, J. D., Rees, R. S., et al. Early role for neutrophils in skin flap failure. Surg. Forum 41: 553, 1990.
17. Carden, D. L., Smith, J. K., and Korthuis, R. J. Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle: Role of granulocyte adherence. Circ. Res. 66: 1436, 1990.
18. Kurose, I., Anderson, D. C., Miyasaka, M., et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ. Res. 74: 336, 1994.
19. Kurose, I., Wolf, R., Grisham, M. B., et al. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74: 376, 1994.
20. Kubes, P., Suzuki, M., and Granger, D. N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88: 4651, 1991.
21. Cooke, J. P., and Tsao, P. S. Cytoprotective effects of nitric oxide. Circulation 88: 2451, 1993.
22. ω-hyroxyl-L-arginine is an intermediate in the byosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266: 6259, 1991.
23. Hecker, M., Sessa, W. C., Harris, H. J., et al. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. U.S.A. 87: 8612, 1990.
24. Moncada, S., Palmer, R. M. J., and Higgs, E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109, 1991.
25. Mills, C. D. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146: 2719, 1991.
26. Mittal, C. K. Nitric oxide synthase: Involvement of oxygen radicals in conversion of L-arginine to nitric oxide. Biochem. Biophys. Res. Commun. 193: 126, 1993.
27. Shiraishi, Y., Lee, J. R., Laks, H., et al. L-arginine administration during reperfusion improves pulmonary function. Ann. Thorac. Surg. 62: 1580, 1996.
28. Payne, D., and Kubes, P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am. J. Physiol. 265: G189, 1993.
29. Linas, S., Whittenburg, D., and Repine, J. E. Nitric oxide prevents neutrophil-mediated acute renal failure. Am. J. Physiol. 272: F48, 1997.
30. Siegfried, M. R., Erhardt, J., Rider, T., et al. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260: 668, 1992.
31. Weyrich, A. S., Ma, X., and Lefer, A. M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279, 1992.
32. Morikawa, E., Huang, Z., and Moskowitz, M. A. L-arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am. J. Physiol. 263: H1632, 1992.
33. Cordeiro, P. G., Mastorakos, D. P., Hu, Q. Y., et al. The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps. Plast. Reconstr. Surg. 100: 1227, 1997.
34. Labbe, R., Lindsay, T., Gatley, R., et al. Quantitation of postischemic skeletal muscle necrosis: Histochemical and radioisotope techniques. J. Surg. Res. 44: 45, 1988.
35. Morris, S. F., Pang, C. Y., Zhong, A., et al. Assessment of ischemia-induced reperfusion injury in the pig latissimus dorsi myocutaneous flap model. Plast. Reconstr. Surg. 92: 1162, 1993.
36. Renlund, D. G., Macfarlane, J. L., Christensen, R. D., et al. A quantitative and sensitive method for measurement of myeloperoxidase. Clin. Res. 28: 75A, 1980.
37. Bradley, P. P., Priebat, D. A., Christensen, R. D., et al. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 296, 1982.
38. Hjortdal, V. E., Hansen, E. S., Kjolseth, D., et al. The influence of tissue tension on the microcirculation in myocutaneous flaps: An experimental study in dogs. Ann. Plast. Surg. 25: 461, 1990.
39. Rajshekhar, V., White, L. M., and Harbaugh, R. E. Acute effects of a pedicled omental graft on cold-induced brain oedema in cats. Acta Neurochir. (Wien) 112: 136, 1991.
40. Zamboni, W. A., Roth, A. C., Russell, R. C., et al. Morphologic analysis of the microcirculaton during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast. Reconstr. Surg. 91: 1110, 1993.
41. Messmer, K., Sack, F. U., Menger, M. D., et al. White cell-endothelium interaction during postischemic perfusion of skin and skeletal muscle. Adv. Exp. Med. Biol. 242: 95, 1988.
42. Granger, D. N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am. J. Physiol. 255: H1269, 1988.
43. Noel, A. A., Hobson, R. W., II, and Duran, W. N. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. Microvasc. Res. 52: 210, 1996.
44. Rubes, P., Ibbotson, G., Russell, J. B., et al. Role of platelet-activating factor in reperfusion-induced leukocyte adherence. Am. J. Physiol. 258: G300, 1990.
45. Palmer, R. M. J., Ashton, D. S., and Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664, 1988.
46. Ma, X.-L., Weyrich, A. S., Lefer, D. J., et al. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72: 403, 1993.
47. McCall, T., Whittle, B. J. R., Boughton-Smith, N. K., et al. Inhibition of fMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br. J. Pharmacol. 95 (Suppl): 517P: 95, 1988.
48. Boyd, J. B., Markland, B., Dorion, D., et al. Surgical augmentation of skin blood flow and viability in a pig musculocutaneous flap model. Plast. Reconstr. Surg. 86: 731, 1990.
49. Pang, C. Y., Dorion, D., Zhong, A. G., et al. Salvage of ischemic skeletal muscle from reperfusion injury (Abstract). FASEB J. 5: A1274, 1991.
50. Labbe, R., Lindsay, T., and Walker, P. M. The extent and distribution of skeletal muscle necrosis after graded periods of complete ischemia. J. Vasc. Surg. 6: 152, 1987.
51. Ma, X.-L., Weyrich, A. S., Lefer, D. J., et al. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72: 403, 1993.
52. Cristol, J. P., Thiemermann, C., Guerin, M. C., et al. L-Arginine infusion alter ischemia-reperfnsion of rat kidney enhances lipid peroxidauon. J. Lipid Mediat. Cell Signal. 13: 9, 1996.
53. Rubanyi, G., and Vanhoutte, P. M. Superoxide anions and hypoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250: H822, 1986.
54. Gryglewski, R. J., Palmer, R. M., and Moncada, S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454, 1986.
55. Kubes, P., and Granger, D. N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262: H611, 1992.
56. Filep, J. G., Foldes-Filep, E., and Sirois, P. Nitric oxide modulates vascular permeability in the rat coronary circulation. Br. J. Phannacol. 108: 323, 1993.
57. Heller, R., Bussolino, F., Ghigo, D., et al. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochem. Pharmacol. 44: 223, 1992.
58. Stotland, M. A., and Kerrigan, C. L. The role of platelet-activating factor in musculocutaneous flap reperfusion injury. Plast. Reconstr. Surg. 99: 1989, 1997.
59. Kirschner, R. E., Fyfe, B. S., Hoffman, L. A., et al. Ischemia-reperfusion injury in myocutaneous flaps: Role of leukocytes and leukotrienes. Plast. Reconstr. Surg. 99: 1485, 1997.
60. Salvemini, D., Masini, E., Pistelli, A., et al. Nitric oxide: A regulatory mediator of mast cell reactivity. J. Cardiovasc. Pharmacol. 17(Suppl 3): S258, 1991.
61. Kubes, P., Kanwar, S., Niu, X.-F., et al. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7: 1293, 1993.
62. Mayhan, W. G. Role of nitric oxide in leukotriene C4-induced increases in microvascular transport. Am. J. Physiol. 265: H409, 1993.
63. Lefer, A. M., and Lefer, D. J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc. Res. 32: 743, 1996.
64. Kurose, I., Kubes, P., and Wolf, R. Inhibition of nitric oxide production: Mechanisms of vascular albumin leakage. Circ. Res. 73: 164, 1993.